A tesamorelin 10mg vial is a research-grade GHRH peptide that ships as a lyophilized powder. Learn dosing, reconstitution, vial sizes, and safety basics.
A tesamorelin 10mg vial is a lyophilized, research-grade vial of tesamorelin acetate that is reconstituted with bacteriostatic water before use. Each 10 mg vial contains enough peptide for roughly 5 to 10 doses at the 1 mg to 2 mg per day range most often described in published tesamorelin research. The prescription drug Egrifta (tesamorelin) is FDA-approved only for excess abdominal fat in adults with HIV and lipodystrophy, so 10mg vials sold for research are not approved for human use.
What Is Actually Inside a Tesamorelin 10mg Vial
Tesamorelin is a synthetic 44-amino-acid growth hormone-releasing hormone (GHRH) analog. It binds GHRH receptors in the pituitary and supports the body's own pulsatile growth hormone release, which in turn raises IGF-1.
A typical tesamorelin 10mg peptide vial contains:
- 10 mg tesamorelin acetate as a lyophilized powder
- Mannitol or a similar bulking and stabilizing agent
- No preservative — the powder is sterile and sealed under vacuum
A tesamorelin 10mg vial is sold as a dry powder, never as a ready-to-inject liquid. Because the peptide is fragile, it must be reconstituted gently and should never be shaken or heated.
Tesamorelin Dosing and How a 10mg Vial Fits In
Clinical trials of tesamorelin used a 2 mg subcutaneous injection once daily. Research protocols reported in the literature most commonly use 1 mg to 2 mg per day, injected subcutaneously, five to seven days per week.
Reconstitution math is straightforward. Adding 2 mL of bacteriostatic water to a 10 mg vial produces a 5 mg/mL solution, so 0.2 mL equals 1 mg. Adding 1 mL instead produces 10 mg/mL, so 0.1 mL equals 1 mg. The 2 mL dilution is usually easier to measure accurately on a U-100 insulin syringe.
Doses Per Vial at Common Research Amounts
| Vial Size | Doses at 1 mg/Day | Doses at 2 mg/Day | Typical BAC Water |
|---|---|---|---|
| 2 mg | 2 | 1 | 1 mL |
| 5 mg | 5 | 2.5 | 1–2 mL |
| 10 mg | 10 | 5 | 1–2 mL |
| 20 mg | 20 | 10 | 2 mL |
| 30 mg | 30 | 15 | 3 mL |
10mg vs 20mg vs 30mg: Which Vial Size Makes Sense
Smaller vials suit short protocols. A tesamorelin 2mg vial is a single dose at the clinical amount, and a tesamorelin 5mg vial covers a brief run or a first-time trial. A 10 mg vial is the most popular middle ground because it covers a typical one- to two-week research window without leaving a large amount of reconstituted peptide sitting in the refrigerator.
Larger formats such as tesamorelin 20mg or tesamorelin 30mg cost less per milligram, but the savings only matter if the entire vial can be used before it degrades. Reconstituted tesamorelin should generally be used within two to four weeks when stored refrigerated at 2°C to 8°C.
How Tesamorelin Compares With Other Research Peptides
Tesamorelin is one of several peptides that act on the growth hormone axis. Many researchers compare it against sermorelin, CJC-1295, and ipamorelin, and a frequent question is tesamorelin vs sermorelin vs cjc-1295, since each has a different half-life, potency, and side-effect profile.
If you are weighing cjc-1295 ipamorelin vs tesamorelin, the practical differences come down to duration of action, injection frequency, and how aggressively each compound raises IGF-1.
| Peptide | Class | Approx. Half-Life | Primary Research Focus |
|---|---|---|---|
| Tesamorelin | GHRH analog | 26–38 minutes | Visceral fat, IGF-1 response |
| Sermorelin | GHRH analog | 10–20 minutes | Growth hormone secretion |
| CJC-1295 (no DAC) | GHRH analog | ~30 minutes | Pulsatile GH release |
| CJC-1295 DAC | GHRH analog | 6–8 days | Sustained IGF-1 elevation |
| Ipamorelin | Ghrelin mimetic | ~2 hours | Selective GH release |
Some protocols also pair aod 9604 with tesamorelin, because AOD-9604 acts on fat metabolism through a pathway that does not overlap with GHRH signaling.
Blends and Stacks Built Around a 10mg Vial
Pre-mixed products such as a 2x blend tesamorelin 10mg ipamorelin 5mg combine a GHRH analog with a ghrelin mimetic in one vial, which cuts the number of vials and reconstitution steps a researcher has to manage.
A cjc 1295 ipamorelin tesamorelin stack is another combination seen in research settings, though overlapping GHRH activity makes the total dose harder to control precisely.
Combination vials are only as good as their documentation. Ask for a lot-specific certificate of analysis before assuming a blend contains what the label claims.
Storage, Handling, and Quality Checks
- Store lyophilized vials in the refrigerator or freezer, protected from light.
- Reconstitute only with bacteriostatic water — never tap water or saline.
- Swirl gently until dissolved; do not shake the vial.
- Keep reconstituted vials at 2°C to 8°C and out of direct light.
- Confirm the solution is clear and particle-free before use.
- Verify HPLC purity and mass spectrometry data on the certificate of analysis.
A reputable tesamorelin 10mg vial ships with a third-party certificate of analysis showing purity above 98% by HPLC. Vague or missing lab documentation is the single most common red flag in this market, and it usually shows up as inconsistent potency between vials.
Safety, Side Effects, and Legal Status
In clinical use, tesamorelin has been associated with injection-site reactions, joint and muscle pain, peripheral edema, and modest increases in blood sugar and IGF-1. It is not appropriate for people with active cancer, pregnant or breastfeeding women, or anyone with disrupted pituitary anatomy.
Tesamorelin is not FDA-approved for general weight loss or athletic performance, and research vials are labeled for laboratory use only. Anyone considering a hormone-related peptide should review it with a licensed healthcare professional, particularly if they take insulin, corticosteroids, or thyroid medication.
Frequently Asked Questions
How much bacteriostatic water should I add to a tesamorelin 10mg vial?
Most people add 1 mL or 2 mL of bacteriostatic water. Adding 2 mL gives a 5 mg/mL solution, so 0.2 mL equals 1 mg; adding 1 mL gives 10 mg/mL, so 0.1 mL equals 1 mg. The 2 mL dilution is easier to measure accurately. Swirl the vial gently until the powder dissolves and never shake it.
How long does a tesamorelin 10mg vial last?
At 1 mg per day, a 10 mg vial provides about 10 doses; at 2 mg per day, about 5 doses. Once reconstituted, tesamorelin should be refrigerated at 2°C to 8°C and used within roughly two to four weeks. Lyophilized, unopened vials last far longer when kept cold and protected from light.
Is a tesamorelin 10mg research vial the same as Egrifta?
No. Egrifta is the FDA-approved prescription version of tesamorelin acetate, approved only for excess abdominal fat in adults with HIV-associated lipodystrophy. Research-grade 10mg vials are sold for laboratory use and are not FDA-approved for human use, and their purity and potency are not guaranteed by the manufacturer.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.